102 gazette notifications — Page 2 of 3
The National Pharmaceutical Pricing Authority extends the validity of notification S.O. 3869(E) regarding ceiling prices for Orthopaedic Knee Implants for Knee Replacement System until November 15, 20…
This order fixes the retail prices, exclusive of Goods and Services Tax, for nine specific drug formulations under the Drugs (Prices Control) Order, 2013.
The Central Government issued three separate orders to further amend the enforcement dates of the Quality Control Orders, 2023, concerning various textile woven sacks, by substituting the effective da…
The National Pharmaceutical Pricing Authority issues an Addendum to its Orders S.O. 1485(E) dated 27th March 2025 and S.O. 3000(E) dated 4th July 2025, adding specific manufacturers and their applicab…
The National Pharmaceutical Pricing Authority fixes the retail prices for various pharmaceutical formulations under the Drugs (Prices Control) Order, 2013.
The National Pharmaceutical Pricing Authority issues an addendum to its previous orders regarding ceiling price fixation of Ringer Lactate formulations, incorporating new manufacturers and their produ…
This addendum modifies the National Pharmaceutical Pricing Authority's Order No. 1486(E) dated 27th March 2025 by adding two manufacturers and specific applicability clauses for ceiling price fixation…
The National Pharmaceutical Pricing Authority fixes the ceiling prices for specific Meropenem Powder for Injection formulations manufactured by M/s Gufic Biosciences Limited, based on their special fe…
The Ministry of Chemicals and Fertilizers, Department of Chemicals and Petrochemicals, directs the mandatory collection of statistics on chemicals and petrochemicals from industries in India via the C…
The National Pharmaceutical Pricing Authority fixes the ceiling prices for specific scheduled formulations, exclusive of Goods and Services Tax, under the Drugs (Prices Control) Order, 2013.
The National Pharmaceutical Pricing Authority fixes the retail prices, exclusive of Goods and Services Tax, for 37 specified drug formulations in exercise of powers under the Drugs (Prices Control) Or…
The Central Government issues the H Acid (Quality Control) Second Amendment Order, 2025, to amend the H Acid (Quality Control) Order, 2024.
The Central Government withdraws the Acetic Acid (Quality Control) Order, 2019, the Methanol (Quality Control) Order, 2019, and the Aniline (Quality Control) Order, 2019.
This notification amends the National Pharmaceutical Pricing Authority's Order No. 1474(E) dated 27th March 2025, concerning the ceiling price fixation of scheduled formulation packs of Ringer Lactate…
The National Pharmaceutical Pricing Authority issued an Addendum (S.O. 3000(E)) to its Order No. 1485(E) dated 27th March 2025, concerning the ceiling price fixation of scheduled formulation packs of …
The National Pharmaceutical Pricing Authority (NPPA) fixes the retail price for the formulation "Paracetamol I.P. 500 mg and Phenylephrine HCl I.P. 10 mg" for M/s GlaxoSmithKline Asia Private Limited.
The National Pharmaceutical Pricing Authority (NPPA) fixes the retail prices for 71 specified drug formulations, including their strengths, units, and associated manufacturer and marketing companies, …
This Order amends the Polypropylene (PP) Materials for Moulding and Extrusion (Quality Control) Order, 2024, to change its effective date.
This Order amends the Poly Vinyl Chloride (PVC) Homopolymers (Quality Control) Order, 2024, to revise its effective date.
This Order amends the Polyethylene Material for Moulding and Extrusion (Quality Control) Order, 2022, by introducing the Polyethylene Material for Moulding and Extrusion (Quality Control) Amendment Or…
The Ministry of Chemicals and Fertilizers amends three Quality Control Orders, 2023, concerning various woven sacks by postponing their effective date of enforcement to September 6, 2025.
The National Pharmaceutical Pricing Authority fixes the retail prices for 41 specific pharmaceutical formulations under the Drugs (Prices Control) Order, 2013.
This Corrigendum amends the manufacturer's name in the National Pharmaceutical Pricing Authority's notification S.O. 4062(E), dated 08.11.2019, relating to the fixation of retail price.
The Central Government amends notification S.O. 1490(E) dated 13th September, 2006, by substituting the entry for serial number 1 with 'Ms. Sukriti Likhi Chairperson'.
Order amending the H Acid (Quality Control) Order, 2024, the K Acid (Quality Control) Order, 2024, and the Vinyl Sulphone (Quality Control) Order, 2024.
Order issued by the National Pharmaceutical Pricing Authority fixing/revising the ceiling price for Iohexol Injection 300mg iodine/ML and providing related directions under the Drugs (Prices Control) …
The National Pharmaceutical Pricing Authority fixes the separate retail prices for specific Fixed Dose Combinations of M/s Otsuka Pharmaceutical India Private Limited under paragraph 11(3) of the Drug…
Order issued by the National Pharmaceutical Pricing Authority fixing the ceiling prices for specific scheduled formulations under the Drugs (Prices Control) Order, 2013.
Notification issued by the National Pharmaceutical Pricing Authority fixing the retail price of specified drug formulations under the Drugs (Prices Control) Order, 2013.
Corrigendum issued by the National Pharmaceutical Pricing Authority correcting entries in notification S.O. 5493(E) dated 19th December 2024 regarding retail price fixation.
Extends the tenure of Shri Justice Anil Verma as Commissioner for the welfare of Bhopal gas leak disaster victims.
Amends several Quality Control Orders for specified fatty acids and oils, changing their effective date to October 24, 2025.
Notifies 26th September 2022 as the date of establishment of the Council under the National Institute of Pharmaceutical Education and Research Act, 1998.
Postpones enforcement of quality control for Vinyl Acetate Monomer and Methyl/Ethyl Acrylate to March 31, 2026.
Revises ceiling prices of scheduled formulations of Glucose and Sodium Chloride injections based on Wholesale Price Index (WPI) increase, effective April 1, 2025.
Revises ceiling prices of scheduled formulations based on annual Wholesale Price Index increase, effective from April 1, 2025, as per Drugs (Prices Control) Order, 2013.
Fixes retail prices of eighty formulations of various pharmaceutical drugs as per the Drugs (Prices Control) Order, 2013.
Fixes ceiling prices for scheduled formulations based on annual Wholesale Price Index increase as per the Drugs (Prices Control) Order, 2013.
Fixes ceiling prices for scheduled drug formulations based on annual Wholesale Price Index increase, effective April 1, 2025.
Revises ceiling prices of scheduled drug formulations based on annual Wholesale Price Index increase of 1.74028% effective from 1.4.2025.
Revises ceiling prices of Piperacillin and Tazobactam injections based on Wholesale Price Index increase, effective April 1, 2025, superseding previous order S.O. No. 1554(E) dated 26.03.2024.
Revises ceiling prices of coronary stents effective April 1, 2025, based on a 1.74028% wholesale price index adjustment for 2024.
Revises ceiling prices for Ringer Lactate injection formulations, effective April 1, 2025, based on a 1.74028% increase in the Wholesale Price Index.
Amends the enforcement date of the p-Xylene (Quality Control) Order, 2021 to December 19, 2025.
Amends the Ethylene Dichloride (Quality Control) Order, 2021, changing the enforcement date to September 12, 2025.
Amends enforcement date of Quality Control Orders for Beta Picoline, Sodium Tripolyphosphate, and Pyridine to March 13, 2026.
Fixes retail prices for various scheduled pharmaceutical formulations under the Drugs (Prices Control) Order, 2013.
Corrects dosage form and strength of Azithromycin in Hindi version of Notification S.O. 659(E) regarding ceiling price revision.
Fixes/revises ceiling prices for scheduled formulations Azithromycin and Amoxicillin + Clavulanic acid under Drugs (Prices Control) Order, 2013, effective from notification date.
Fixes the retail price of Cilnidipine & Telmisartan Tablets manufactured by M/s Akums Drugs & Pharmaceuticals Ltd. and M/s Glenmark Pharmaceuticals Limited.